Quick Answer
QIAGEN N.V. reported Total Assets of $6.28 billion for fiscal year 2025.
QIAGEN N.V. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $6.28B | +10.4% |
| 2024 | $5.69B | -7.0% |
| 2023 | $6.12B | -2.7% |
| 2022 | $6.29B | +2.3% |
| 2021 | $6.15B | +4.7% |
| 2020 | $5.87B | +12.1% |
| 2019 | $5.24B | -8.9% |
| 2018 | $5.75B | +14.1% |
| 2017 | $5.04B | +17.0% |
| 2016 | $4.31B | +3.1% |
| 2015 | $4.18B | -6.2% |
| 2014 | $4.45B | +9.0% |
| 2013 | $4.09B | +0.0% |
| 2012 | $4.09B | +9.6% |
| 2011 | $3.73B | -4.7% |
| 2010 | $3.91B | +3.1% |
| 2009 | $3.80B | — |
- QIAGEN N.V. showed an increase of +10.4% in Total Assets compared to the prior fiscal year.
- Over the 2009–2025 period, QIAGEN N.V.’s total assets has grown by 65.4% (from $3.80 billion to $6.28 billion).
- The most recent figure is from QIAGEN N.V.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: